semaglutide nausea law firm in kentucky The 2 sides of Ozempic โ weight loss success stories and health nightmares ๐จ BIG NEWS FOR KENTUCKY
Description
Martin-Timon I, Sevillano-Collantes C, Segura-Galindo A, Del Canizo-Gomez FJ
Health records and insurance claims data showed half (n = 85,015) started treatment with GLP-1 receptor agonists between 2013 and 2023
Side Effects & Safety Per REDEFINE 1 and the Lau (2021) phase 2 program, trial-reported adverse events include: Nausea -- most common (25-40%)
Breast cancer was diagnosed 12 years ago as stage II triple-negative breast cancer, for which she underwent a mastectomy
Another credited Measured for helping her lose weight gained from PCOS after years of struggle
